HENOGEN
ActiveHoldings and subsidiaries
2 holdingsHoldings 2
Source for every holding own accounts 2025
- GINKGO PARCsubsidiaryEquity €994,783 Profit of €668,685 in 2025 (profit of €381,346 in 2024) Checked score 98100%
- Equity €7.9m Profit of €768,785 in 2025 (profit of €179,662 in 2024) Checked score 951.33%
Holdings through the years 2006 to 2025
| Name | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GINKGO PARC | 100% | |||||||||||||||||||
| EEBIC | 0.7% | 1.4% | 1.33% | |||||||||||||||||
| EUROBIOTEC BRUSSELS | 15% | |||||||||||||||||||
| ImmunotokoNL | 82% | 100% | ||||||||||||||||||
Source: list of holdings in its own accounts
Connections & network
3 current directorsThe network starts from the directors of HENOGEN. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.